An Effective Protocol for Management of International Arrivals at Risk in COVID-19 Pandemic: Experience From the Pre-Hospital Covid-19 Response Teams at Xi'an, China.
COVID-19
China
control
transmission
travel
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
08
2021
accepted:
04
01
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) outbreak within China has been well controlled and stabilized since early April 2020. Therefore, the current major focus in China is to prevent the introduction of COVID into China from international arrivals. To achieve this, pre-Hospital COVID-19 Response Teams (pHCRTs) have been established. The pHRCTs were established in Xi'an, China in early 2020. During the 12 months covered in this report, there were 356 international flight arrivals with over 5,000 COVID-19 Nucleic Acid Test (NAT) positive people, 500 of them with symptomatic COVID-19 and requiring admission to special hospitals. All other arrivals were managed in dedicated facilities by pHRCTs. The outcome measure of this report was the number of positive cases among the pHRCT members. Four hundred forty-two staff worked in the pHCRTs during the reporting period. Despite multiple throat swab PCR tests during their pHRCTs tour of duty, and the subsequent mandatory 14-day quarantine required before return to the general community, no staff became NAT positive. The prevention of community transmission from imported cases is a vital part of the strategy to maintain the low numbers of cases in countries which have achieved control, or suppression of local internal cases. The program of pHCRTs described in this article gives successful protocols for transportation of patients who are infectious based on the minimal transmission of virus and staff safety. The strategies employed may prove useful in future pandemics.
Sections du résumé
Background
The coronavirus disease 2019 (COVID-19) outbreak within China has been well controlled and stabilized since early April 2020. Therefore, the current major focus in China is to prevent the introduction of COVID into China from international arrivals. To achieve this, pre-Hospital COVID-19 Response Teams (pHCRTs) have been established.
Context
The pHRCTs were established in Xi'an, China in early 2020. During the 12 months covered in this report, there were 356 international flight arrivals with over 5,000 COVID-19 Nucleic Acid Test (NAT) positive people, 500 of them with symptomatic COVID-19 and requiring admission to special hospitals. All other arrivals were managed in dedicated facilities by pHRCTs. The outcome measure of this report was the number of positive cases among the pHRCT members.
Details
Four hundred forty-two staff worked in the pHCRTs during the reporting period. Despite multiple throat swab PCR tests during their pHRCTs tour of duty, and the subsequent mandatory 14-day quarantine required before return to the general community, no staff became NAT positive.
Conclusion
The prevention of community transmission from imported cases is a vital part of the strategy to maintain the low numbers of cases in countries which have achieved control, or suppression of local internal cases. The program of pHCRTs described in this article gives successful protocols for transportation of patients who are infectious based on the minimal transmission of virus and staff safety. The strategies employed may prove useful in future pandemics.
Identifiants
pubmed: 35321200
doi: 10.3389/fpubh.2022.753640
pmc: PMC8936669
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
753640Informations de copyright
Copyright © 2022 Zou, Zou, Dart, Zhang, Wang and Fan.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Brain Behav Immun. 2020 Aug;88:950-951
pubmed: 32311493
J Hosp Infect. 2021 Jan;107:103-104
pubmed: 33039454
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32634217
Diagn Microbiol Infect Dis. 2020 Sep;98(1):115094
pubmed: 32623267
Acute Med Surg. 2020 Jul 13;7(1):e536
pubmed: 32685174
PLoS One. 2015 Nov 05;10(11):e0142149
pubmed: 26540446
Dermatol Ther. 2020 Jul;33(4):e13310
pubmed: 32170800
BMJ. 2020 Jun 10;369:m2195
pubmed: 32522737
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Lancet Public Health. 2018 Aug;3(8):e385-e394
pubmed: 30033200